Home/Filings/4/0001053310-22-000001
4//SEC Filing

KAY E GERALD 4

Accession 0001053310-22-000001

CIK 0001016504other

Filed

May 5, 8:00 PM ET

Accepted

May 6, 5:08 PM ET

Size

4.9 KB

Accession

0001053310-22-000001

Insider Transaction Report

Form 4
Period: 2022-05-06
KAY E GERALD
DirectorCEO and President10% Owner
Transactions
  • Award

    Common Stock

    2022-05-06$0.23/sh+100,000$23,0005,345,889 total
Footnotes (1)
  • [F1]100,000 common stock shares acquired upon exercise of stock option grant dated May 24, 2019.

Issuer

INTEGRATED BIOPHARMA INC

CIK 0001016504

Entity typeother

Related Parties

1
  • filerCIK 0001053310

Filing Metadata

Form type
4
Filed
May 5, 8:00 PM ET
Accepted
May 6, 5:08 PM ET
Size
4.9 KB